Navigation Links
Amyloid beta in the brain of individuals with Alzheimer's disease
Date:3/30/2012

The deposition of amyloid beta in the brain of individuals with Alzheimer's disease is the focus of much research into both its cause and treatment.

While there may not be a consensus as to whether the deposition contributes to the disease or is a consequence of the disease, there is agreement that it is not favoured thermodynamically, meaning that something else is promoting the process.

Other proteins are often co-deposited in vivo with amyloid beta and one such protein is serum amyloid P component (or SAP). Recent evidence has suggested that SAP is elevated in Alzheimer's disease and a team of researchers from Keele University in Staffordshire, UK, led by Professor Chris Exley, has shown that physiologically-significant concentrations of SAP promote the deposition of amyloid beta under conditions approaching those found in vivo.

Professor Exley said: "We have shown that SAP is bound by fibrils of amyloid beta and that this interaction stabilises the fibrils over timescales which are physiologically significant. This is the first example of a physiologically significant biomolecule promoting and stabilising the formation of amyloid fibrils of amyloid beta 42 under near-physiological conditions."

The group also found that this property of SAP was enhanced in the presence of aluminium, a metal which has also been shown to be co-deposited with amyloid beta in Alzheimer's disease. There have been recent efforts to reduce the plasma concentration of SAP as a therapy for Alzheimer's disease and the research provides strong evidence that SAP is involved in the deposition of amyloid beta 42 in Alzheimer's disease and that by reducing the plasma concentration of SAP it might also reduce the deposition of amyloid beta. Their observations support serum amyloid P component as a therapeutic target in Alzheimer's disease.


'/>"/>
Contact: Chris Stone
c.w.stone@mac.keele.ac.uk
44-178-273-3375
IOS Press
Source:Eurekalert

Page: 1

Related biology news :

1. Early role of mitochondria in AD may help explain limitations to current beta amyloid hypothesis
2. New therapy targets for amyloid disease
3. Scientists remove amyloid plaques from brains of live animals with Alzheimers disease
4. Autism risk gene linked to differences in brain structure
5. New discoveries about brain-hand connection sought to improve therapies, treatments, prosthetics
6. Friendly to a fault, yet tense: Personality traits traced in brain
7. Nanotherapy: Treating deadly brain tumors by delivering big radiation with tiny tools
8. University of Alberta led research may have discovered how memories are encoded in our brains
9. Step forward in research into new treatments for brain edema
10. The Japanese traditional therapy, honokiol, blocks key protein in inflammatory brain damage
11. Strong scientific evidence that eating berries benefits the brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2019)... ... August 14, 2019 , ... Join Jonathan Riek, PhD, ... on Tuesday, September 10, 2019 at 1pm EDT to learn about two common ... management. , NAFLD is the most common diffuse liver disease, with a worldwide ...
(Date:8/14/2019)... ... August 14, 2019 , ... Gateway Genomics , a ... announces inclusion in the 38th annual Inc. 500|5000 list of fastest growing ... qualify, companies must have been founded and generating revenue by March 31, 2015. Ranking ...
(Date:8/14/2019)... (PRWEB) , ... August 13, 2019 , ... Dr. Julie Reck of Veterinary Medical ... to her patients. Her first stem cell patient, her own geriatric Australian Shepherd, Simon, ... to Dr. Reck, Simon wanted to play but his body was weak, and he struggled ...
Breaking Biology News(10 mins):
(Date:7/30/2019)... ... July 30, 2019 , ... The summer season has been ... Not only has the company already hosted many of its signature cooking classes ... its guests. , With Lajollacooks4u’s Private Cooking Parties, guests prepare and enjoy a ...
(Date:7/19/2019)... ... July 18, 2019 , ... ... Everest,” will be joining forces with California-based charity Coalition Duchenne for its 9th ... Coalition Duchenne raises awareness and funding for Duchenne muscular dystrophy and was founded ...
(Date:7/11/2019)... LAS VEGAS (PRWEB) , ... July 11, 2019 , ... ... 2019, R3 provided complimentary regenerative therapies to eight military Veterans under the R3 Heroes ... procedures being complimentary. , The R3 Heroes Program allow anyone to nominate a military ...
(Date:6/26/2019)... ... June 26, 2019 , ... Alice Branton today released ... improving physicochemical properties of Magnesium Gluconate, which can prove to be beneficial for treating ... of characteristic differentiation peak, change in crystallite size , Over 142% increase ...
Breaking Biology Technology: